Abstract:Background CHCHD2 was identified a novel cell migration-promoting gene, which could promote cell migration and altered cell adhesion when ectopically overexpressed in NIH3T3 fibroblasts, and it was identified as a protein necessary for OxPhos function as well. However, the clinic relevance of CHCHD2 expression in NSCLC remains unclear. Here we assumed that CHCHD2 expression would accompanies the expression of HIF-1α to response hypoxia in the occurrence of NSCLC. Methods In order to verify this hypothesis, correlations among the expression levels of CHCHD2 and HIF-1α were detected and analyzed in 209 pair cases of NSCLC. The expression and location of these molecules were assessed using Immunohistochemistry, immunohistofluorescence, qRT-PCR and western blotting. The differences and correlations of the expression of these two molecules with clinical pathological characteristics in NSCLC were statistically analyzed using Wilcoxon (W) text, Mann-Whitney U, Kruskal-Wallis H and cross-table tests. Kaplan-Meier survival analysis and Cox proportional hazards models were used to estimate the effect of the expression of CHCHD2 and HIF-1α on the patients’ survival. Results Data showed that CHCHD2 and HIF-1α expression were higher in NSCLC than in normal tissues (all P = 0.000). CHCHD2 expression was significantly related with smoking, tumor size, differentiation degree, TNM Stage, lymph metastasis (all P< 0.05). The HIF-1α expression was significantly associated with smoking, tumor category, differentiation degree, TNM Stage, Lymph metastasis (all P< 0.05). There was a marked correlation of CHCHD2 and HIF-1α expression with histological type, differentiation and lymph metastasis of NSCLC (all P< 0.05, r s > 0.3). Immunohistofluorescence showed that there were co-localization phenomenon in cytoplasm and nucleus between CHCHD2 and HIF-1α expression. NSCLC patients with higher CHCHD2 and HIF-1α expression had a significantly worse prognosis than those with lower CHCHD2 and HIF-1α expression (all P = 0.0001; log-rank test). The multivariate analysis indicated that CHCHD2 expression was an independent prognostic factor in NSCLC (hazard ratio [HR], 0.492, P = 0.001). Conclusion Our results indicate that over-expression of CHCHD2 would promote the expression of HIF-1α to adapt the hypoxia microenviroment in NSCLC and CHCHD2 could serves as a prognostic biomarker in NSCLC.

Expression and clinical significance of CHCHD2 in non-small cell lung cancer patients

[Value of CHCHD2 as a potential marker of non-small cell lung cancer: analysis of 60 cases].

CHCHD2 is a Potential Prognostic Factor for NSCLC and is Associated with HIF-1a Expression.

Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis

CHCHD2 Promotes Hepatocellular Carcinoma and Indicates Poor Prognosis of Hepatocellular Carcinoma Patients

Expression of the cyclooxygenase-2 gene and its clinical significance in non-small cell lung cancer

Overexpression of CHD1L is Positively Associated with Metastasis of Lung Adenocarcinoma and Predicts Patients Poor Survival

Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer

Expression and clinical significance of EphA2,E-cad and VEGF in human non-small cell lung cancer

[A study on the relationship between the level of E-cadherin mRNA expression and pathological characteristics of non-small cell lung cancer].

Expression of P21, P53 and C-Erbb-2 in Tissues of Non-Small Cell Lung Cancer and Its Clinical Significance

Chd4 is Associated with Poor Prognosis of Non- Small Cell Lung Cancer Patients Through Promoting Tumor Cell Proliferation

Expression of CDC2,CLDN5 and its clinical significance in esophageal squamous cell carcinoma

EXPRESSION OF EZH2 IN NON-SMALL CELL LUNG CANCER AND ITS CLINICAL SIGNIFICATION

[Expression and Its Clinical Significance of HMGA2 in the Patients with Non-Small Cell Lung Cancer.].

EXPRESSION OF HMGA2 AND ITS RELATIONSHIP WITH CELL PROLIFERATION IN NON-SMALL CELL LUNG CANCER

Expression of Dishevelled 2 Gene and Protein in Clear-Cell Renal Cell Carcinoma Tissues and Its Clinical Significance

Expression and clinical significance of Bcl-2 in non-small cell lung carcinoma

Study on detecting overexpression of HER2 and HER1 in NSCLC and their clinical significance

[Expression of two transcript variants of long noncoding RNA C6orf176 in non-small cell lung cancer and its clinical significance].

Expression and prognostic significance of the VEGFR-2 gene in human parenchyma of NSCLC